Literature DB >> 10158943

EuroQol: the current state of play.

R Brooks1.   

Abstract

The EuroQol Group first met in 1987 to test the feasibility of jointly developing a standardised non-disease-specific instrument for describing and valuing health-related quality of life. From the outset the Group has been multi-country, multi-centre, and multi-disciplinary. The EuroQol instrument is intended to complement other forms of quality of life measures, and it has been purposefully developed to generate a cardinal index of health, thus giving it considerable potential for use in economic evaluation. Considerable effort has been invested by the Group in the development and valuation aspects of health status measurement. Earlier work was reported upon in 1990; this paper is a second 'corporate' effort detailing subsequent developments. The concepts underlying the EuroQol framework are explored with particular reference to the generic nature of the instrument. The valuation task is reviewed and some evidence on the methodological requirements for measurement is presented. A number of special issues of considerable interest and concern to the Group are discussed: the modelling of data, the duration of health states and the problems surrounding the state 'dead'. An outline of some of the applications of the EuroQol instrument is presented and a brief commentary on the Group's ongoing programme of work concludes the paper.

Mesh:

Year:  1996        PMID: 10158943     DOI: 10.1016/0168-8510(96)00822-6

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  1820 in total

1.  Public involvement in health care priority setting: an economic perspective.

Authors:  Tracy Roberts; Stirling Bryan; Chris Heginbotham; Alison McCallum
Journal:  Health Expect       Date:  1999-12       Impact factor: 3.377

2.  Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

Authors:  X Badia; S Monserrat; M Roset; M Herdman
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

3.  The dawn of a new century: reflections on surgical issues.

Authors:  A Cuschieri
Journal:  Surg Endosc       Date:  2000-01       Impact factor: 4.584

4.  Sample size calculations in studies using the EuroQol 5D.

Authors:  M Roset; X Badia; N E Mayo
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

Review 5.  Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Authors:  J Brown; M Sculpher
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

6.  Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication.

Authors:  J L Bosch; M G Hunink
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

7.  Assessment of quality of life in lung transplantation using a simple generic tool.

Authors:  A C Anyanwu; A McGuire; C A Rogers; A J Murday
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

8.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

Authors:  B Conner-Spady; C Cumming; J M Nabholtz; P Jacobs; D Stewart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

9.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

10.  Measuring Quality of Live in Disorders of Sleep and Breathing.

Authors:  Marlene Reimer; W. Ward Flemons
Journal:  Sleep Breath       Date:  1999       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.